These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 339433)

  • 1. Mechanisms of cardiac allograft rejection in the inbred rat: the effect of complement depletion by cobra venom factor on hyperacute cardiac allograft rejection.
    Whittum JA; Lindquist RR
    Transplantation; 1977 Sep; 24(3):226-8. PubMed ID: 339433
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of anticomplementary cobra venom factor on hyperacute rat cardiac allograft rejection.
    Forbes RD; Pinto-Blonde M; Guttmann RD
    Lab Invest; 1978 Nov; 39(5):463-70. PubMed ID: 366280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy.
    Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S
    Transplant Proc; 2006 Dec; 38(10):3263-5. PubMed ID: 17175243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A passive transfer model of hyperacute rat cardiac allograft rejection.
    Forbes RD; Guttmann RD; Pinto-Blonde M
    Lab Invest; 1979 Oct; 41(4):348-55. PubMed ID: 385979
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged cardiac allograft survival in mouse model after complement depletion with Yunnan cobra venom factor.
    Wu W; Wang HD; Zhu XX; Lan G; Yang K
    Transplant Proc; 2009 Dec; 41(10):4321-7. PubMed ID: 20005392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cyclosporine, total lymphoid irradiation, and cobra venom factor on hyperacute rejection.
    Knechtle SJ; Halperin EC; Murphy CE; Saad T; Abernethy K; Miller D; Bollinger RR
    J Heart Transplant; 1985; 4(5):541-5. PubMed ID: 3916531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
    Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for complement-induced endothelial injury in vivo: a comparative ultrastructural tracer study in a controlled model of hyperacute rat cardiac allograft rejection.
    Forbes RD; Guttmann RD
    Am J Pathol; 1982 Mar; 106(3):378-87. PubMed ID: 7039333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat strain differences in complement activity correlate with hyperacute rejection of guinea pig cardiac xenografts.
    Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
    Transplant Proc; 1993 Oct; 25(5):2848-9. PubMed ID: 8212257
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonessential role of neutrophils as mediators of hyperacute cardiac allograft rejection in the rat.
    Forbes RD; Guttmann RD; Kuramochi T; Klassen J; Knaack J
    Lab Invest; 1976 Mar; 34(3):229-34. PubMed ID: 765621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunological responsiveness in mice decomplemented with cobra venom factor.
    Rumjanek VM; Brent L; Pepys MB
    Immunology; 1978 Jun; 34(6):1117-23. PubMed ID: 355121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preconditioning with ozone abrogates acute rejection and prolongs cardiac allograft survival in rats.
    Stadlbauer TH; Eisele A; Heidt MC; Tillmanns HH; Schulz S
    Transplant Proc; 2008 May; 40(4):974-7. PubMed ID: 18555093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic lymphocytes are rejected in hyperacute fashion by enhanced rats bearing a heart allograft from the same donor.
    Olszewski WL; Orlewska E; Ryffa T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):244-5. PubMed ID: 2650111
    [No Abstract]   [Full Text] [Related]  

  • 16. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation.
    Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1995 Apr; 27(2):1583-4. PubMed ID: 7725417
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of graft preservation and acute rejection on hypoxia-inducible factor-1 in rat cardiac allografts.
    Keränen MA; Nykänen AI; Krebs R; Tuuminen R; Sandelin H; Koskinen PK; Lemström KB
    Transplant Proc; 2006 Dec; 38(10):3372-3. PubMed ID: 17175275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of complement suppression on xenograft survival in hyperacute rejection.
    Mukai S; Orihashi K; Sueda T; Kajihara H; Matsuura Y
    Hiroshima J Med Sci; 1999 Mar; 48(1):17-24. PubMed ID: 10213959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.